SanlialpSCSanlialpMGulerS. CHA2DS2-VASc-HSF score may better predict the development of total coronary artery occlusion in acute coronary syndrome. Angiology. 2021;000331972110403. doi:10.1177/00033197211040348.
2.
YaşarEBayramoğluAKarakuşYÇakmakT. The CHA2DS2-VASc risk score predicts total occlusion in infarct-related arteries in patients with non-ST elevation myocardial infarction. Angiology. 2021;000331972110313. doi:10.1177/00033197211031324.
3.
HindricksGPotparaTDagresN, et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2020;42:373-498.
4.
JanuaryCTWannLSCalkinsH, et al. AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Circulation. 2019;140:e125-e151.
5.
ChanY-HYiuK-HLauK-K, et al. The CHADS2 and CHA2DS2-vasc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation. Atherosclerosis. 2014;237:504-513.
6.
ÇınarTHayıroğluMITanıkVO, et al. The predictive value of the CHA2DS2-VASc score in patients with mechanical mitral valve thrombosis. J Thromb Thrombolysis. 2018;45:571-577.
7.
BayramoğluABektasO. CHA2DS2-VASc score is a predictor of angiographic high thrombus burden in patients with ST-Segment elevation myocardial infarction. J Clin Anal Med. 2019;10:426-430.